Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 21
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Encephale ; 49(5): 460-465, 2023 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-35973848

RESUMEN

INTRODUCTION: The Level of Service/Case Management Inventory (LS/CMI) is one of the best-known recidivism risk instruments. In France, this scale is rarely used because no study had yet been carried out to confirm its psychometric properties on samples of French offenders. The aim of this study was to test the psychometric properties of the LS/CMI on samples of violent French prisoners. METHOD: The Level of Service/Case Management Inventory, the BARR-2002R, Historical Clinic Risk-Scale 20 and the Risk for Sexual Violence Protocol were administered to 128 violent offenders. RESULTS-DISCUSSION: The results showed good internal consistency, reliability and convergent validity of the LS/CMI. Assault, robbery and sexual assault were correlated with the LS/CMI. All of these results are discussed and analysed using the international reference literature. CONCLUSION: Confirmation of the psychometric properties of the LS/CMI among French offenders to allow it to be used to assess the risk of recidivism of offenders.


Asunto(s)
Criminales , Reincidencia , Humanos , Manejo de Caso , Reproducibilidad de los Resultados , Medición de Riesgo/métodos
2.
Drug Dev Ind Pharm ; 31(9): 827-49, 2005 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16305995

RESUMEN

Coelenterazine and derivatives were initially considered in the scientific community for their (bio)luminescent properties. Now, another interest of such hetero-bicycles has been pointed out by the discovery of remarkable antioxidative properties, and an unique mode of action as a "cascade": the mother-compound (imidazolopyrazinone) is transformed by ROS into a daughter-compound (2-amino-pyrazine) also endowed with antioxidative properties. This review illustrates the therapeutic potential of synthetic imidazolopyrazinones (coelenterazine analogues): chemical reactivity assays with singulet oxygen, radical anion superoxide, peroxynitrite, and radicals formed during lipid and LDL peroxidation, cellular tests of protection against oxidative stress using keratinocyte, hepatocyte, neuronal and erythrocyte cells, and finally in vivo evaluation in a hamster model of ischemia-reperfusion, are fully described.


Asunto(s)
Antioxidantes/síntesis química , Antioxidantes/farmacología , Imidazoles/síntesis química , Imidazoles/farmacología , Pirazinas/síntesis química , Pirazinas/farmacología , Animales , Antioxidantes/toxicidad , Diseño de Fármacos , Hemólisis/efectos de los fármacos , Humanos , Imidazoles/química , Imidazoles/toxicidad , Peroxidación de Lípido/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Oxidación-Reducción , Estrés Oxidativo/efectos de los fármacos , Ácido Peroxinitroso/química , Pirazinas/química , Pirazinas/toxicidad , Protectores contra Radiación/farmacología , Especies Reactivas de Oxígeno/química , Superóxidos/química
3.
Anticancer Drugs ; 15(5): 499-502, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15166625

RESUMEN

Temozolomide (Temodal) is an oral imidazotetrazine. Increased temozolomide exposure and subsequent depletion of O-alkylguanine alkyltransferase may improve the activity of temozolomide. The rationale for investigating temozolomide plus Caelyx is based on their antitumor activity, their formulation and no significant overlapping toxicities. We conducted a study of a prolonged schedule of temozolomide (orally on days 1-7 and 15-21) plus Caelyx (day 1) every 28 days. Twenty-one patients (melanoma n=10, sarcoma n=7 and other n=4) were assigned to four dose levels (DL; temozolomide+Caelyx, mg/m): DL1: 100+30 (n=3 patients), DL2: 100+40 (n=6 patients), DL3: 125+40 (n=6 patients) and DL4: 150+40 (n=6 patients). Dose-limiting toxicities were noted after 2 or more cycles in one patient at DL3 (stomatitis) and one patient at DL4 (grade 4 ANC >/=7 days). Treatment delays and/or dose reductions (due to hematological toxicity) were necessary in five of six patients receiving DL4 compared with one of six patients at DL3, and one patient at DL1 and 2. Thus, the recommended dose was temozolomide 125 mg/m (daily for 7 days every other week) plus Caelyx 40 mg/m (day 1 every 4 weeks). Other toxicities were mild. Antitumor activity was observed in eight patients, including one complete response (melanoma), three partial responses (one melanoma, two sarcomas) and four patients with stable disease (three melanomas, one Ewing), with a duration lasting from 14 to 135+weeks. Two melanoma patients showed tumor stabilization in non-irradiated cerebral lesions. This schedule of temozolomide allowed higher dose intensity (1750 mg/m in 4 weeks) compared to the standard 5-day regimen (1000 mg/m in the same amount of time).


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Dacarbazina/análogos & derivados , Neoplasias/tratamiento farmacológico , Adulto , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Dacarbazina/administración & dosificación , Doxorrubicina/administración & dosificación , Esquema de Medicación , Femenino , Humanos , Infusiones Intravenosas , Liposomas , Masculino , Dosis Máxima Tolerada , Persona de Mediana Edad , Neutropenia/inducido químicamente , Estomatitis/inducido químicamente , Temozolomida , Resultado del Tratamiento
4.
Free Radic Res ; 34(3): 285-96, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11264902

RESUMEN

Coelenterazine (3,7-dihydro-2-(p-hydroxybenzyl)-6-(p-hydroxyphenyl)-8-benzylimidazolo[1,2-a]pyrazin-3- one) is a substrate for the bioluminescence reaction in many marine animals. Recent work showed that CLZn, its synthetic analogue CLZm, and their common oxidation product coelenteramine (CLM) have strong antioxidative properties in acellular lipid peroxidation systems as well as in rat hepatocytes subjected to tert-butyl hydroperoxide (t-BHP). Here, we analyzed the ability of CLZm and several imidazolopyrazinone (IMPZs) analogues to protect primary cultures of rat hepatocytes against a nitrofurantoin (NF)-induced oxidative stress. Comparison of protection capabilities with reference antioxidants yielded the following ranking: CLZm >>> BHT >Trolox C((R)) > probucol > alpha-tocopherol. The comparison of CLZm with analogues lacking the phenol group in R(1) revealed no differences although the presence of this phenol conferred superior protection against t-BHP. CLM, as well as its methoxylated analogue mCLM which lacks chain-breaking properties, were equally potent in preventing cellular damage caused by NF. mCLM and alpha-naphthoflavone, an inhibitor of cytochrome P450 (CYP450) IAI, similarly protected cells against NF-induced mortality and also equally inhibited EROD activity in methylcholanthrene-induced hepatocytes. The inhibition of EROD by CLZm and CLM was less pronounced. We suggest that the extent of protection conferred by IMPZs against NF-toxicity reflects both the occurrence of antioxidative properties detoxifying ROS produced within cells and inhibitory actions on CYP450 isoforms involved in the bioreduction of NF.


Asunto(s)
Antioxidantes/farmacología , Hepatocitos/metabolismo , Nitrofurantoína/efectos adversos , Estrés Oxidativo/efectos de los fármacos , Pirazinas/farmacología , Animales , Benzoflavonas/farmacología , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Citocromo P-450 CYP1A1/efectos de los fármacos , Citocromo P-450 CYP1A1/metabolismo , Relación Dosis-Respuesta a Droga , Hepatocitos/efectos de los fármacos , Peroxidación de Lípido/efectos de los fármacos , Masculino , Oxidación-Reducción , Ratas , Ratas Wistar , terc-Butilhidroperóxido/farmacología
5.
Biochem Pharmacol ; 60(4): 471-8, 2000 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-10874121

RESUMEN

Coelenterazine (CLZn; 3, 7-dihydro-2-(p-hydroxybenzyl)-6-(p-hydroxyphenyl)-8-benzylimidazolo++ +[1 ,2-a]pyrazin-3-one), the substrate for bioluminescence reactions in many marine animals, is endowed with high antioxidant properties. This work investigated the antioxidative properties of CLZn in primary cultures of rat hepatocytes subjected to the oxidant tert-butyl hydroperoxide (t-BHP). Micromolar concentrations of CLZn increased survival and decreased lipid peroxidation in rat hepatocytes subjected for 6 hr to 2.5 x 10(-4) M t-BHP. However, the extent of protection was limited by a strong toxicity of CLZn (IC(50) = 6.9 x 10(-5) M). The presence of t-BHP increased the cellular toxicity of CLZn. Methyl coelenterazine (CLZm, 3, 7-dihydro-2-methyl-6-(p-hydroxyphenyl)-8 benzylimidazolo[1, 2-a]pyrazin-3-one), a synthetic analogue of CLZn, demonstrated excellent antioxidant properties, even at very low (3 x 10(-6) M) concentrations and was not toxic throughout most of its effective concentration range. CLZm proved far more effective than reference antioxidants such as Trolox C(R), alpha-tocopherol, BHT, and probucol. The assay of thiobarbituric reactive substances (TBARS) associated with cells and in the culture medium indicated that 10(-5) M CLZm provided a total protection against t-BHP-induced lipid peroxidation. This coelenterazine analogue could be used as a model compound for investigating the action mechanism of imidazolopyrazinones in mammalian hepatocytes.


Asunto(s)
Antioxidantes/farmacología , Imidazoles , Hígado/efectos de los fármacos , Estrés Oxidativo/fisiología , Pirazinas/farmacología , terc-Butilhidroperóxido/farmacología , Animales , Relación Dosis-Respuesta a Droga , Interacciones Farmacológicas , Técnicas In Vitro , Peroxidación de Lípido/efectos de los fármacos , Hígado/citología , Masculino , Ratas , Ratas Wistar
6.
J Biol Chem ; 275(29): 21960-8, 2000 Jul 21.
Artículo en Inglés | MEDLINE | ID: mdl-10791951

RESUMEN

A senescence-like growth arrest is induced in mouse primary embryo fibroblasts by inhibitors of phosphoinositide 3-kinase (PI3K). We observed that senescence-like growth arrest is correlated with an increase in p27(Kip1) but that down-regulation of other cyclin-dependent kinase (CDK) inhibitors, including p15(INK4b), p16(INK4a), p19( INK4d), and p21(Cip1) as well as other negative cell cycle regulators such as p53 and p19(ARF), implies that this senescence-related growth arrest is independent of the activity of p53, p19(ARF), p16(INK4a), and p21(Cip1), which are associated with replicative senescence. The p27(Kip1) binds to the cyclin/CDK2 complexes and causes a decrease in CDK2 kinase activity. We demonstrated that ectopic expression of p27(Kip1) can induce permanent cell cycle arrest and a senescence-like phenotype in wild-type mouse embryo fibroblasts. We also obtained results suggesting that the kinase inhibitors LY294002 and Wortmannin arrest cell growth and induce a senescence-like phenotype, at least partially, through inhibition of PI3K and protein kinase B/Akt, activation of the forkhead protein AFX, and up-regulation of p27(Kip1)expression. In summary, these observations taken together suggest that p27(Kip1) is an important mediator of the permanent cell cycle arrest induced by PI3K inhibitors. Our data suggest that repression of CDK2 activity by p27(Kip1) is required for the PI3K-induced senescence, yet mouse embryo fibroblasts derived from p27(Kip1-/-) mice entered cell cycle arrest after treatment with LY294002. We show that this is due to a compensatory mechanism by which p130 functionally substitutes for the loss of p27(Kip1). This is the first description that p130 may have a role in inhibiting CDK activity during senescence.


Asunto(s)
Proteínas de Ciclo Celular , Senescencia Celular/fisiología , Proteínas Asociadas a Microtúbulos/metabolismo , Fosfatidilinositol 3-Quinasas/metabolismo , Transducción de Señal/fisiología , Proteínas Supresoras de Tumor , Animales , División Celular/fisiología , Células Cultivadas , Cromonas/farmacología , Inhibidor p27 de las Quinasas Dependientes de la Ciclina , Quinasas Ciclina-Dependientes/antagonistas & inhibidores , Regulación hacia Abajo , Inhibidores Enzimáticos/farmacología , Fibroblastos , Ratones , Morfolinas/farmacología
7.
J Exp Biol ; 201(Pt 8): 1211-21, 1998 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9510532

RESUMEN

Bioluminescence, the emission of ecologically functional light by living organisms, emerged independently on several occasions, yet the evolutionary origins of most bioluminescent systems remain obscure. We propose that the luminescent substrates of the luminous reactions (luciferins) are the evolutionary core of most systems, while luciferases, the enzymes catalysing the photogenic oxidation of the luciferin, serve to optimise the expression of the endogenous chemiluminescent properties of the luciferin. Coelenterazine, a luciferin occurring in many marine bioluminescent groups, has strong antioxidative properties as it is highly reactive with reactive oxygen species such as the superoxide anion or peroxides. We suggest that the primary function of coelenterazine was originally the detoxification of the deleterious oxygen derivatives. The functional shift from its antioxidative to its light-emitting function might have occurred when the strength of selection for antioxidative defence mechanisms decreased. This might have been made possible when marine organisms began colonising deeper layers of the oceans, where exposure to oxidative stress is considerably reduced because of reduced light irradiance and lower oxygen levels. A reduction in metabolic activity with increasing depth would also have decreased the endogenous production of reactive oxygen species. Therefore, in these organisms, mechanisms for harnessing the chemiluminescence of coelenterazine in specialised organs could have developed, while the beneficial antioxidative properties were maintained in other tissues. The full range of graded irradiance in the mesopelagic zone, where the majority of organisms are bioluminescent, would have provided a continuum for the selection and improvement of proto-bioluminescence. Although the requirement for oxygen or reactive oxygen species observed in bioluminescent systems reflects the high energy required to produce visible light, it may suggest that oxygen-detoxifying mechanisms provided excellent foundations for the emergence of many bioluminescent systems.


Asunto(s)
Adaptación Fisiológica/fisiología , Comunicación Animal , Evolución Biológica , Mediciones Luminiscentes , Oxígeno/metabolismo , Oxígeno/fisiología , Animales
8.
Presse Med ; 19(12): 549-52, 1990 Mar 31.
Artículo en Francés | MEDLINE | ID: mdl-2139215

RESUMEN

A geneological study made it possible to establish a link between two medullary thyroid carcinoma families from Normandy totalling 9 sick subjects, and a probable link with a third family. The study contributed to the diagnosis of multiple endocrine neoplasia type IIa, whereas the condition had been diagnosed for 6 years as familial medullary thyroid carcinoma, without phaechromocytoma. Group in these two families together increased the number of subjects tested, thereby facilitating genetic link analysis and enabling the link with markers of the disease on chromosome 10 to be asserted. The genetic study can now be used to detect individuals at risk, and with regular laboratory tests the diagnosis will be made at the "precancerous" stage. A genealogical study going back to the family-founding couple will increase the population which will benefit from screening in this region north of Rouen.


Asunto(s)
Carcinoma/genética , Neoplasias de la Tiroides/genética , Neoplasias de las Glándulas Suprarrenales/genética , Adulto , Niño , Cromosomas Humanos Par 10 , Femenino , Humanos , Hiperparatiroidismo/complicaciones , Masculino , Persona de Mediana Edad , Linaje , Feocromocitoma/genética
9.
Nouv Presse Med ; 6(26): 2323-6, 1977 Jun 25.
Artículo en Francés | MEDLINE | ID: mdl-887417

RESUMEN

Of a total of 102 cases of male infertility seen over the past ten years, treatment resulted in normalisation of the sperm count in 26, with 12 normal pregnancies resulting. These results concerned cases of oligo-asthenospermia related to a varicocele, pyospermia, hormonal insufficiency or general and psychological disorders. Ten couples were able to have a child with the use of artificial insemination using fresh donor sperm. The abandonment of this technique, nor replaced by the use of frozen sperm provided by a sperm bank, results at the present time in a considerable reduction in the number of inseminations, associated with the overload of these banks. Nevertheless, half of all couples accept the principle of hetero-insemination. The number of couples adopting a child is very low (4% in this study) as a result not only of the difficulties of adoption but also refusal by the couple.


Asunto(s)
Infertilidad Masculina/terapia , Adopción , Congelación , Humanos , Infertilidad Masculina/clasificación , Infertilidad Masculina/etiología , Inseminación Artificial Heteróloga , Masculino , Conservación de Tejido
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA